Date: Monday, June 3, 2019
Session Time: 4:30pm-6:00pm
Presentation Time: 5:18pm-5:30pm
Location: Room 306
*Purpose: End-stage renal disease is associated with premature ageing of the T-cell immune system. At the time of kidney transplantation the average biological age of the circulating T cell system is increased by 15-20 years over the calendar age, but inter-individual variation is substantial. The hypothesis was tested that advanced immunological T-cell ageing increases the long-term mortality risk after kidney transplantation.
*Methods: Patients from a well-defined cohort (N=210), transplanted with a kidney from a living donor between 2010-2013, were included. All recipients received induction therapy with basiliximab and prednisone/MMF/tacrolimus. Circulating T cells were analyzed before and at 3, 6 and 12 months after transplantation . The number of CD31-expressing naive T cells (identifying recent thymic emigrants, a marker for thymic function), telomere length and differentiation status of T cells were assessed by flow cytometry. The results were validated in a cohort of 180 kidney transplant recipients transplanted between 2007-2010.
*Results: Thirty recipients (median age 63 year, range 26-78) died during follow-up until sept 2018. The absolute numbers of naive CD4+ (living:258 cells/ul vs. deceased:101 cells/ul, p=0.001) and naive CD8+ T cells (living:97 cell/ul vs. deceased:37 cells/ul, p=0.001) were significantly lower in the deceased group prior to transplantation. Numbers of naive CD31+ T cells were inversely related with increasing age (r=0.56, p<0.001). However, the average numbers of naive CD4+CD31+ and CD8+CD31+ T cells in the deceased patient group was at the level of patients >75 years, independent of age. In a multivariate proportional hazard analysis including recipient age, the number of naive CD4+ T cells remained associated with all-cause mortality (HR 0.98, CI 0.98-0.99, p<0.001). The lowered number of naive CD4+ T cells in the deceased patient group was primarily caused by a decreased thymic function (less CD31+ naive T cells). In addition, a compensatory increase in CD31– naive T cells, which is normally observed with age-related loss of thymic function, was not observed. Within the first year after transplantation, the number and characteristics of naive T cells remained remarkably stable. All other immunological parameters assessed were not related to patient survival after transplantation.
*Conclusions: Advanced immunological T-cell ageing at time of transplantation, defined by a severe reduction in thymic function, is highly associated with all-cause mortality after kidney transplantation.
To cite this abstract in AMA style:Betjes MG, Langerak A, Klepper M, Litjens N. Advanced Immunological T-cell Ageing Defined by a Very Low Thymic Function Identifies Patients with a Substantial Increased Risk for Long-Term Mortality after Kidney Transplantation [abstract]. Am J Transplant. 2019; 19 (suppl 3). https://atcmeetingabstracts.com/abstract/advanced-immunological-t-cell-ageing-defined-by-a-very-low-thymic-function-identifies-patients-with-a-substantial-increased-risk-for-long-term-mortality-after-kidney-transplantation/. Accessed May 18, 2021.
« Back to 2019 American Transplant Congress